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Abstract
Background: Plasmodium falciparum-parasitized red blood cells (RBCs) are equipped with protective antioxidant enzymes and
heat shock proteins (HSPs). The latter are only considered to protect against thermal stress. Important issues are poorly
explored: first, it is insufficiently known how both systems are expressed in relation to the parasite developmental stage;
secondly, it is unknown whether P. falciparum HSPs are redox-responsive, in view of redox sensitivity of HSP in eukaryotic cells;
thirdly, it is poorly known how the antioxidant defense machinery would respond to increased oxidative stress or inhibited
antioxidant defense. Those issues are interesting as several antimalarials increase the oxidative stress or block antioxidant
defense in the parasitized RBC. In addition, numerous inhibitors of HSPs are currently developed for cancer therapy and might
be tested as anti-malarials. Thus, the joint disruption of the parasite antioxidant enzymes/HSP system would interfere with
parasite growth and open new perspectives for anti-malaria therapy.
Methods: Stage-dependent mRNA expression of ten representative P. falciparum antioxidant enzymes and hsp60/70–2/70–3/
75/90 was studied by quantitative real-time RT-PCR in parasites growing in normal RBCs, in RBCs oxidatively-stressed by
moderate H2O2 generation and in G6PD-deficient RBCs. Protein expression of antioxidant enzymes was assayed by Western
blotting. The pentosephosphate-pathway flux was measured in isolated parasites after Sendai-virus lysis of RBC membrane.
Results: In parasites growing in normal RBCs, mRNA expression of antioxidant enzymes and HSPs displayed co-ordinated
stage-dependent modulation, being low at ring, highest at early trophozoite and again very low at schizont stage. Additional
exogenous oxidative stress or growth in antioxidant blunted G6PD-deficient RBCs indicated remarkable flexibility of both
systems, manifested by enhanced, co-ordinated mRNA expression of antioxidant enzymes and HSPs. Protein expression of
antioxidant enzymes was also increased in oxidatively-stressed trophozoites.
Conclusion: Results indicated that mRNA expression of parasite antioxidant enzymes and HSPs was co-ordinated and stage-
dependent. Secondly, both systems were redox-responsive and showed remarkably increased and co-ordinated expression in
oxidatively-stressed parasites and in parasites growing in antioxidant blunted G6PD-deficient RBCs. Lastly, as important anti-
malarials either increase oxidant stress or impair antioxidant defense, results may encourage the inclusion of anti-HSP molecules
in anti-malarial combined drugs.
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Background
During the intraerythrocytic development of Plasmodium
falciparum, reactive oxygen species (ROS) are produced by
both the parasite and the host red blood cells (RBCs)
[1,2]. To cope with ROS and maintain a redox equilib-
rium, the parasites are equipped with effective scavengers,
such as reduced glutathione (GSH) [3-5], thioredoxins
[6], and protective antioxidant enzymes present in the
cytosol, mitochondrion or apicoplast that directly inacti-
vate ROS or regenerate scavengers [7-11]. Protection of all
subcellular compartments from oxidative stress is impor-
tant and the biosynthesis of [Fe-S] clusters in both apico-
plast and mitochondrion is particularly prone to
oxidation and needs to be protected from ROS [12]. Plas-
modium appears to be equipped with antioxidant systems
in its organelles and a superoxide dismutase and a func-
tional peroxiredoxin system are localized in the mito-
chondrial compartment [10,11].
In addition to antioxidant enzymes the parasite is
equipped with a number of heat shock proteins (HSPs)
[13,14] that form a second protective system against stress
present in falciparum  malaria, notably against thermal
stress typical for this disease. HSPs are highly conserved
and universally present molecular chaperones that protect
cell structures and organelles against thermal, chemical
and redox stress. In addition, HSPs play crucial roles in
folding/unfolding/assembly of proteins, transport/sorting
of proteins into correct subcellular compartments, cell-
cycle control, signaling, and antigen presentation [see ref.
[15] and [16] for review]. Several HSPs are localized in the
mitochondria [12,17-20] supporting the hypothesis that
both cytosol and organelles are subjected to stress. Both
protective systems are essential for parasite survival, and
drugs that inhibit or interfere with the first or second sys-
tem may lead to parasite death.
Present work addresses issues that received little attention
so far: the first one is how antioxidant enzymes and HSPs
are expressed in relation to the parasite development in
the RBC. The second issue is whether and how P. falci-
parum HSPs take part into antioxidant defense, and are
modulated by oxidative stress possibly in a co-ordinated
way with the antioxidant enzyme system. Redox-sensitiv-
ity of HSPs is unexplored in Plasmodium, although a
number of HSPs are remarkably redox-responsive in most
eukaryotic cells [12,19-24]. The third issue regards how
the antioxidant enzymes and HSPs respond to increased
oxidative stress or inhibited antioxidant defense. Such
response is of interest because the joint disruption of the
antioxidant enzymes/HSP system of the parasite would
interfere with parasite growth or enhance their removal by
the host's phagocytes and open new perspectives of com-
bined anti-malarial therapy. Indeed, a number of anti-
malarials such as chloroquine and artemisinin, peroxidic
antimalarials, anthroquinones and xanthones exert their
activity, at least in part, by increasing the oxidative stress
in the parasitized RBC [25-27], while others such as inhib-
itors of parasitic glutathione reductase aim at inhibiting
antioxidant defense mechanisms [28,29]. In addition,
widespread genetic RBC defects protective against malaria
such as glucose-6-phosphate dehydrogenase (G6PD) defi-
ciency, sickle-cell trait and β-thalassaemia impose an
additional oxidative stress upon host and parasite, and
induce early removal of parasitized RBCs by the host's
phagocytes [30,31]. In analogy to other eukaryotic cell
systems [2,7,17-24], parasitic genes encoding antioxidant
enzymes and HSPs may upmodulate their responses, and
thus reduce efficacy of redox-active drugs. Inhibition of
antioxidant enzymes and HSPs may thus represent a way
to kill the parasites or to enhance their phagocytic
removal.
In the present study, stage-dependent mRNA expression
of representative cytosolic and mitochondrial antioxidant
enzymes and HSPs was assessed by quantitative real-time
RT-PCR (qRT-PCR) in P. falciparum growing in normal,
unstressed RBCs, in oxidatively stressed RBCs, and in
G6PD-deficient RBCs that are characterized by blunted
antioxidant defense. The study parameters included ten
Pf-antioxidant enzymes: glutathione peroxidase-like
thioredoxin peroxidase (GPx-like TPx), glutathione
reductase (GR), glutathione S-transferase (GST), glutare-
doxin-1 (Grx), thioredoxindependent peroxidases (1-Cys-
Prx, 2-Cys-Prx), thioredoxin reductase (TR), superoxide
dismutases-1 and -2 (SOD-1, SOD-2), G6PD; a glycolytic
enzyme, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH); and a panel of five Pf-HSPs: HSP60, HSP70–2,
HSP70–3, HSP75 and HSP90. By analogy with other
eukaryotic cells, these genes/proteins are likely to respond
to oxidant stress [20-24].
Results indicate that mRNA expression of both parasite
antioxidant enzymes and HSPs was strictly co-ordinated
and stage-dependent attaining highest values at early tro-
phozoite stage and declining afterwards; secondly, in par-
asites developing in oxidatively stressed normal RBCs and
in G6PD-deficient RBCs, characterized by blunted anti-
oxidant defense, both systems were redox-responsive and
showed increased mRNA and protein expression. As
important anti-malarials either increase oxidant stress or
decrease antioxidant defense, results may encourage the
inclusion of anti-HSPs molecules in combined anti-
malarial drugs.
Methods
Materials
Buffers, RPMI 1640 culture medium containing Hepes,
methionine-free RPMI 1640, mannitol, octylphenyl-poly-
ethylene glycol (IGEPAL CA-630), gentamicin, xanthineMalaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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(X), xanthine oxidase (XO), superoxide dismutase (SOD),
allopurinol and SYBR Green 1 were from Sigma, St. Louis,
Missouri, USA; Percoll was from Pharmacia, Uppsala,
Sweden; RLN lysis buffer was prepared according to RNe-
asy Mini Handbook, Qiagen, Milano, Italy; DNA-free™
DNase Treatment & Removal Reagents was from Ambion,
Austin, Texas, USA; Tran35S-label was from MP Biochem-
icals, Irvine, CA; D- [1-14C] glucose was from Amersham
International, Amersham, UK; Diff-Quik parasite stain
was from Baxter Dade AG, Dudingen, Switzerland; Stand-
ard RNA Releaser was from Nurex, Sassari, Italy; RNa-
seOut RibonucleaseInhibitor, M-MLV reverse
transcriptase, oligo-dT and Platinum Taq DNA polymer-
ase were from Invitrogen, Milano, Italy; sterile plastics
were from Falcon, Becton Dickinson Labware, Franklin
Lakes, NJ; nitrocellulose transfer membranes were from
Whatman-Schleicher & Schuell, Dassel, Germany; West
Pico Chemiluminescent Substrate was from Pierce, Rock-
ford, Illinois, USA. Bradford reagent was from Bio-Rad,
Hercules, California, USA. All other reagents were pur-
chased from common commercial sources.
Plasmodium falciparum cultivation and isolation of 
parasitized RBCs
Venous peripheral blood samples were collected from
haematologically healthy subjects and from hemizygous
male subjects with the Mediterranean G6PD variant
(residual G6PD activity <5%). In all cases, informed con-
sent was obtained. Blood anticoagulated with citrate-
phosphate-dextrose with adenine (CPDA-1) was kept for
12 to 24 h at 4°C and used for parasite growth experi-
ments, metabolic and mRNA studies. Normal and G6PD-
deficient RBCs were isolated from plasma and white
blood cells by 80% Percoll gradient centrifugation and
three washes in wash medium (RPMI 1640 containing 25
mM HEPES). For parasite growth experiments, metabolic
studies and mRNA studies, P. falciparum parasites (Palo
Alto strain, Mycoplasma-free) were cultivated at 2% hae-
matocrit and synchronized as already described [30-32].
Briefly, normal schizont stage parasitized RBCs separated
on mannitol containing (6% w/v) 40/80% discontinuous
Percoll gradient (parasitaemia >95%) were mixed with
normal or G6PDdeficient RBCs suspended in growth
medium (RPMI 1640 medium containing 25 mM Hepes,
30 mM glucose, 2 mM glutamine, 2 mM adenine, 24 mM
NaHCO3, 32 mg/l gentamicin, and 10% AB or A human
serum, pH 7.4) to start reinfection (time 0). After 6 h incu-
bation, cultures were separated on Percoll 40/80/90% dis-
continuous gradient and haemozoin and schizonts
eliminated. The parasite ring stages (parasitaemia approx.
20%) were collected from the 80–90% interface, washed
three times in wash medium, resuspended in growth
medium and incubated for a further 4 h. At this time (10
h after reinfection), cultures were supplemented or not
with xanthine oxidase (XO)/xanthine (X) and allopurinol
(A) in various combinations (see below). Parasite aliquots
were collected at 13 (early ring stage), 16 (late ring stage),
19 (early trophozoite stage), 28 (late trophozoite stage)
and 46 (schizont stage) h after reinfection. To assess para-
sitaemia, slides were prepared from cultures, stained with
Diff-Quik parasite stain, and 400 to 1,000 cells examined
microscopically. Significance of differences in parasitae-
mia between control, XO/X, XO/X+A and G6PD-deficient
parasitized RBCs was assessed by t-test for paired samples.
Exogenous oxidative stress by XO-X treatment
Oxidative stress in form of continuous extracellular gener-
ation of hydrogen peroxide, was provided by supplement-
ing cultures with low XO/X (XO [EC 1.1.3.22 from bovine
milk, 1–2 U/mg protein] 0.1 mU/ml; X, 1 mM), or high
XO/X (XO, 1 mU/ml; X, 1 mM) as indicated [24,25]. SOD
(EC 1.15.1.1 from bovine RBCs, 2,500–7,000 U/mg pro-
tein) was added throughout at 100 U/ml to enhance for-
mation of hydrogen peroxide from superoxide radical
anions generated by the XO-catalyzed oxidation of X [33].
Low and high XO/X resulted in a constant steady-state lev-
els of approx. 0.44 μM and approx. 4.4 μM hydrogen per-
oxide in the parasite culture, respectively [34]. Allopurinol
(A) (50 μM), a scavenger of ROS and inhibitor of XO, was
added or not as indicated [35].
[35S]-biosynthetic labelling of P. falciparum proteins
For protein labelling of synchronous parasites, asynchro-
nous P. falciparum culture separations were carried out on
Percoll 40/80% discontinuous gradient. Schizont stage
parasites were washed once in methionine-free RPMI
1640 and reinfection carried out in methionine-free RPMI
1640 supplemented with 10% human serum. At 10 h after
reinfection, cultures were treated or not for 13 h with
high/low XO/X with/without A. After incubation, cultures
were resuspended in 0.5 ml of the same medium supple-
mented with Tran35S-label at 50 μCi/ml and incubated for
3 h at 37°C. After incubation, cultures were washed once
in ice-cold PBS, 2 ml of ice-cold 20% (w/v) trichloroacetic
acid (TCA) were added and the mixture was placed for 10
min on ice. Protein precipitates were washed once with 10
ml of cold 20% TCA and 5 ml of cold 10% TCA on a nitro-
cellulose filter paper (type GS, pore size 0.22 μm, Milli-
pore) and air-dried. Protein concentration was
determined using the Bradford method (Bio-Rad). Radio-
activity was measured as counts/min (cpm)/mg protein in
a liquid scintillation counter.
Extraction of P. falciparum total RNA
Total RNA was extracted at 13, 16, 19, 28 and 46 h after
reinfection from synchronized cultures of parasitized nor-
mal RBCs, parasitized normal RBCs treated with low XO/
X and parasitized G6PD-deficient RBCs. Before the extrac-
tion of total RNA, 200 μl of parasitized RBCs (18–20%
parasitaemia) were lysed in 200 μl RLN Buffer (50 mMMalaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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Tris-HCl, pH 8.0, 140 mM NaCl, 1.5 mM MgCl2, 0.5% (v/
v) octylphenyl-polyethylene glycol (IGEPAL CA-630) and
1000 U/ml of RNAse inhibitor) and incubated for 5 min
on ice. Lysates were centrifuged at 300 × g for 5 min at
4°C. Supernatants were collected and pellets discarded.
RNA was extracted from the supernatants using Standard
RNA Releaser (Nurex) and chloroform according to the
manufacturer's instructions. Sample lysates with Standard
RNA Releaser and chloroform were centrifuged and the
upper aqueous layer carefully transferred into a new tube,
taking care to avoid the region just above the interface
where DNA accumulates. RNA digestion was carried out
using the DNA-free™ DNase Treatment & Removal Rea-
gents (Ambion) to completely remove genomic parasite
DNA contamination according to the manufacturer's
instructions. No traces of DNA were observed in our
experiments. cDNA was prepared adding 30 μl of
extracted RNA (corresponding to 18 μg RNA), to 48 μl
reaction mixture containing 300 ng oligo-dT and 600 U
M-MLV reverse transcriptase.
Quantitative real-time RT-PCR of enzymes and HSPs
mRNA expression levels of ten parasite antioxidant
enzymes: GPx-like TPx, GR, GST, Grx, 1-Cys-Prx, 2-Cys-Prx,
TR, SOD-1, SOD-2, G6PD; one parasite glycolytic enzyme,
GAPDH; and five parasite HSPs: HSP60, HSP70–2,
HSP70–3, HSP75, and HSP90, were measured by qRT-
PCR. All oligonucleotide sequences were identified using
Beacon Designer Software (PREMIER Biosoft International,
Palo Alto, CA). Primer pairs of amplicons analysed by qRT-
PCR are shown in Table 1. Five μl of serial dilutions (1:10
to 1:1000) of cDNA from 200 μl of P. falciparum untreated
control sample were used to generate a standard curve.
Assays were performed on the iCycler instrument (BIO-
RAD, Hercules, CA), in a final volume of 25 μl containing
5 μl of cDNA diluted 1:10, 200 nM primer pairs, 1.25 U of
Taq Platinum DNA polymerase, 3 mM MgCl2, 200 μM
dNTPs and 1.7 μl of SYBR-Green diluted 1:10,000. DNA
polymerase was pre-activated for 2 min at 94°C and the
amplification was performed by a 40-cycles PCR (94°C, 30
sec; 62°C, 40 sec; 72°C, 30 sec). All reactions were run in
triplicate. Quantification of PCR results was assessed with
the 2-ΔΔCt method [36]. The relative amounts of mRNAs
were calculated using Pf-18S rRNA as a stage-dependent
internal standard [37]. All analysed transcripts exhibited
high linearity amplification plots (r>0.98) and similar PCR
efficiency (see Table 1), confirming that the expression of
each of these genes can be directly compared to one
another. The specificity of PCR results was confirmed by
melting curve analysis. The melting temperatures for each
amplification product are indicated in Table 1.
Protein expression of antioxidant enzymes
Protein expression was studied in early trophozoite stages
separated 19 h after reinfection from synchronized cul-
tures of parasitized normal RBCs untreated or treated with
low XO/X. Parasites were isolated from host RBCs by
Sendai-virus treatment (see below) and lysed by addition
of lysis buffer (100 mM Hepes, pH 7.4, 5 mM MgCl2, 10
mM EDTA, 0.5% TritonX-100, 5 μg/ml RNAse, 1 mM
PMSF, 1 mM benzamidine, 2 μg/ml leupeptin, 10 μM E-
64, 2 μM 1,10-phenanthroline, 4 μM pepstatin A) fol-
lowed by three cycles of freeze-thawing (dry ice/37°C)
and brief sonication before centrifugation at 16,000 g at
4°C for 20 min. The supernatant was treated for 5 min on
ice with 1 volume of ice-cold butanol/chloroform (3:1.2,
pre-chilled to -20°C) to remove haemoglobin contamina-
tion from the protein lysate. The mixture was then centri-
fuged at 16,000 g at 4°C for 10 min and the protein lysate
(aqueous phase) was transferred to a fresh tube. Protein
concentration was determined using the Bradford method
(Bio-Rad). Equal amounts of protein of non-treated con-
trol lysates and lysates of treated parasites (10 μg) were
separated on a 4–12% SDS-PAGE (Invitrogen) and pro-
teins were subsequently blotted onto nitrocellulose
(Whatman-Schleicher & Schuell) using a semi-dry transfer
method as per manufacturer's instructions (Bio-Rad).
Equal loading and transfer efficiency was also verified by
Ponceau staining of the blots. The blots were hybridized
with polyclonal antibodies directed against P. falciparum
thioredoxin-dependent peroxidases (1-Cys-Prx, 2-Cys-
Prx), thioredoxin reductase, superoxide dismutases (SOD-
1 and -2), and glutathione reductase. Subsequently the
blots were hybridized with the secondary anti-rabbit or rat
horseradish peroxidase coupled antibody (Promega) at
1:5,000 for 1 h, washed in the same buffer as before and
the proteins were detected using the Super Signal West
Pico Chemiluminescent Substrate according to the manu-
facturer's instructions (Pierce) followed by densitometry.
Protein expression changes in oxidatively stressed cells vs
untreated controls was expressed as -fold variation of
band densitometry.
Measurement of pentose phosphate pathway (PPP) flux 
by [14C]-CO2 production from D- [1-14C] glucose. Assay of 
G6PD activity
PPP flux was measured in trophozoites growing in normal
or G6PD-deficient RBCs, treated or not for 18 h with XO-
X by assessing the [14C]-CO2 production from D- [1-14C]
glucose [30]. Trophozoites were treated with Sendai virus
(30  μg/ml, corresponding to 800 haemagglutination
units) that selectively lyses RBC without affecting the par-
asite membranes [30,32]. Sendai-virus treated tropho-
zoite-parasitized RBC were suspended in RPMI 1640
(without NaHCO3, but containing 25 mM Hepes, 20 mM
glucose, 1 μCi/ml D- [1-14C] glucose and 32 mg/l gen-
tamicin, pH 7.4) at 5% haematocrit. After 90 min of pre-
incubation at 37°C, [14C]-CO2 production was measured
as indicated [30]. For G6PD activity measurements, tro-
phozoites growing in normal or G6PD-deficient RBCsMalaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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were treated with Sendai virus, washed and lysed by three
cycles of freeze-thawing (dry ice/37°C). Production of
[14C]-CO2 was expressed as μmol/1010 cells/h at 37°C.
G6PD activity was measured spectrophotometrically at
340 nm and 37°C in the lysate as indicated [38].
Statistical analysis
Values are expressed as mean ± SEM unless otherwise
noted. The number of experiments is indicated by n. Sig-
nificant differences between groups were assessed by one-
way ANOVA followed by the Duncan's multiple-range test
or Student's t-test depending on the experiments. p < 0.05
was chosen as the level of significance.
Results
To optimize maximal exogenous oxidative stress compat-
ible with full viability of P. falciparum, parasites were
grown in presence of varying XO activities at constant 1
mM × concentration. The highest XO activity (XO 0.1
mU/ml, resulting in a constant steady-state level of
approx. 0.44 μM hydrogen peroxide in the parasite culture
[34]), which did not inhibit P. falciparum growth and par-
asitic protein synthesis was used throughout. Higher XO
activity (XO 1 mU/ml, resulting in a constant steady-state
level of approx. 4.4 μM hydrogen peroxide in the parasite
culture [34]) totally abrogated protein synthesis due to
the cytotoxic effect of the treatment (Table 2).
Table 1: Primer pairs of amplicons analysed by qRT-PCR
Gene 
Name
Gene ID
(Entrez 
Nucleotide 
NCBI)
Gene ID
(Plasmo
DB)
(5' → 3') Primer Sequences Prod.
Tm
Ampl.
size
Effic.
Forward Reverse °C (bp) (%)
18S rRNA M19172 MAL1_18s CAAGGAAGTTTAAGGCAACAACAG CATATCTTTCAATCGGTAGGAGCG 86 313 100.9
GAPDH AF030440 PF14_0598 TGGAATTGTTGAAGGTTTAATG CTGGAATAATGTTGGATAATGC 85.5 128 98.8
GPx Z68200 PFL0580w TCGATGCATGATGAAAATGGAACG AATCTAACGGGTTTGTTTTGGGTG 82 118 100.3
GR AF027825 PF14_0192 GTTTAGGTGGAACGTGTGTCAAC GGTGTCAAATCCGTAATGCCTGG 83.5 110 99.3
Grx AF276083 PFC0271c CCCATATTGTATTAAGGCAATT TTCTCAATGTTTTCTACATGC 79 78 100.3
GST AY014840 PF14_0187 GCTTGGAGATAATATAGTGTTATA CTATTCCAAGGTAGGCAAAA 78.5 86 100.2
1-Cys-Prx AF294425 PF08_0131 GGGCTATTTTATTTAGTCACCCAC TTGATCGTGAGATTCTTTGGAGTT 83 146 96.6
2-Cys-Prx AB037568 PF14_0368 TGGTAGATCAGTTGAGGAAGTCTT CACTAACACCTTCTTCTGATGGTT 85.5 131 97.4
TR X87095 PFI1170c ATGGTGCATGTGGATATTCAGAAG TGTCGATGAACAGCAGATATTTCC 80 177 99.8
SOD-1 Z49819 PF08_0071 TTGTGGTGGTGAGCCTCATGG CCCCAACCGGAACCAAAATGAC 82 84 100.1
SOD-2 AY586514 PFF1130c TTTAACCACAATTTCTTTTGGC CACTTCCAAAATGACCTGATG 78.7 151 98.7
Hsp601 U38963 PF10_0153 CCAGTCATCCTTATTAGTTATAGC CTATATCATGAATCAAGGCTTTTC 82.5 149 99.5
Hsp70–22 M18836 PFI0875w ATGCCAACCAATCATTGTTAAATT ATTCGTCACTATCTACATCTTCGT 84 89 100.5
Hsp70–33 AB050740 PF11_0351 TTAGTTGGTGGTATGACTAGAATG TTAATACACCTCCTTGTATAGCAG 83.5 133 100
Hsp754 M28261 PF08_0054 AATTTCCCAGGAGGTATGCCC TTCTTCAACTGTTGGTCCACTTC 90 75 97.9
Hsp905 X13014 PF07_0029 CATGACTAGCTATATGTTATCCAA AAGAGGTATCAAATAATAACCAGA 81.5 143 100.3
1PlasmoDB nomenclature (PDB): hsp60; 2 PDB: Heat shock protein (72 kDa); 3PDB: Heat shock protein hsp 70 kDa homologue (73 kDa); 4PDB: heat 
shock 70 kDa protein (75 kDa); 5PDB: heat shock protein 86.Malaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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Stage-dependent mRNA expression of antioxidant 
enzymes and HSPs in parasites growing in normal RBCs
Stage-dependent mRNA expression of ten parasitic anti-
oxidant enzymes and five HSPs was measured by qRT-
PCR in P. falciparum growing in unstressed normal RBCs.
Taking as a reference mRNA expression levels at early ring
stage, a remarkably coordinated and homogenous
increase in both antioxidant enzymes and HSPs expres-
sion was observed (Figure 1). All mRNA species increased
approx. 1.7-2-fold from ring to early trophozoite stage at
19 h after reinfection. mRNA expression stayed high for
all mRNA species considered from hour 19 to hour 28
(late trophozoite stage) and declined smoothly until the
hour 46 stage (schizont stage).
Stage-dependent mRNA expression of antioxidant 
enzymes, GAPDH and HSPs in parasites growing in 
oxidatively stressed normal RBCs
The effect of exogenous oxidative stress exerted by XO/X
treatment on the stage-dependent mRNA expression of
parasitic antioxidant enzymes and HSPs is shown in Fig-
ure 2. Taking as a reference mRNA expression levels at
early ring stage, all mRNA species except GAPDH were
enhanced in parasites growing in oxidatively stressed nor-
mal RBCs. Remarkable enhancement in expression during
the ring-to-trophozoite transition (hour 13 to hour 19)
was observed in all genes except GAPDH with between 4-
to 8-fold increases. Following genes were higher respond-
ers: SOD-1, 15.4-fold increase; SOD-2, 13.4-fold; HSP60,
12.9-fold; and HSP70–2, 14.9-fold. Addition of allopuri-
nol, a specific inhibitor of XO [34], caused approx. 60%
decrease of the gene expression enhancements induced by
the XO/X treatment, indicating that ROS production was
likely responsible for enhancement of gene expression of
both antioxidant enzymes and HSPs.
Stage-dependent mRNA expression of antioxidant 
enzymes and HSPs in parasites growing in G6PD-deficient 
RBCs
The effect of parasite growth in G6PD-deficient RBCs on
the stage-dependent mRNA expression of parasitic anti-
oxidant enzymes and HSPs is shown in Figure 3. The
mRNA expression pattern of parasitic antioxidant
enzymes and HSPs was also modulated stage-dependently
and all considered parameters significantly increased in
the ring-to-trophozoite transition: GPx-like TPx (6.1-
fold), GR (12.8-fold), Grx (6.0-fold), GST (5.6-fold), 1-
Cys-Prx (4.1-fold), SOD-1 and SOD-2 (3.7-fold), G6PD
(2.6-fold), HSP60 (8.5-fold), HSP70–2 (7.5-fold),
HSP70–3 (4.7-fold), HSP75 (15.8-fold), and HSP90 (6.1-
fold). The kinetics of stage-dependent mRNA expression
was apparently not affected by the G6PD-deficient status
of the host RBCs, as gene expression of all parameters
peaked at 19 h after reinfection and declined afterwards.
As shown in Figure 4, comparison to oxidatively-stressed
parasites indicates that peak expression of several genes
was significantly lower in parasites growing in
G6PDdeficient RBCs: TR (2.4- vs 7.3-fold), SOD-1 (3.7 vs
15.4), SOD-2 (3.7 vs 13.4), G6PD (2.6 vs 6.7), HSP60
(8.5 vs 12.9), HSP70–2 (7.5 vs 14.9). Peak expression was
not significantly different in all other genes, except GR
and HSP75 where peak expression was much greater in
parasites growing in G6PD-deficient RBC (GR, 12.8- vs
4.4-fold; HSP75, 15.8 vs 4.8).
Comparison to parasites growing in oxidatively stressed
normal RBCs was not possible, as XO/X treatment of par-
asitized G6PD-deficient RBCs severely impaired their via-
bility as indicated by morphological changes and decrease
in PPP flux (see below).
Protein expression of antioxidant enzymes in parasites 
growing in normal and oxidatively stressed RBCs
The effect of oxidative stress on protein expression was
studied by Western blotting and band densitometry in a
panel of selected antioxidant enzymes in early tropho-
zoite stage parasites growing in normal and oxidatively
stressed RBCs. As shown in Figure 5, protein expression of
SOD-1, SOD-2, TR, 1-Cys-Prx, 2-Cys-Prx and GR was
increased in oxidatively stressed trophozoite stages. Pro-
tein expression increases in oxidatively stressed cells vs
untreated controls, displayed as change in band densit-
ometry, were remarkable for SOD-1 (4.5-fold), SOD-2
(3.1-fold), TR (2.3-fold), 1-Cys-Prx (2.5-fold) and less evi-
dent for 2-Cys-Prx and GR (1.5-fold and 1.2-fold, respec-
tively).
PPP flux and G6PD enzyme activity in Sendai-virus-treated 
trophozoites growing in oxidatively stressed normal RBCs 
and in G6PD-deficient RBCs
PPP flux reflects the in vivo activity of G6PD, the first and
pace-keeping enzyme of the pathway and the main pro-
ducer of NADPH, the reductant utilized by the GSH- and
thioredoxin-dependent antioxidant systems of the para-
site. PPP flux was measured in Sendai-virus treated tro-
Table 2: Effect of exogenous oxidative stress on protein synthesis 
in trophozoite stage parasitized normal RBCs
Sample Treatment % Inhibition
Parasitized normal RBCs 0 0
Parasitized normal RBCs low XO/X 0
Parasitized normal RBCs high XO/X 100
Parasites were grown at low XO (0.1 mU/ml) or high XO (1 mU/ml) 
activity at constant × concentration (1 mM final) as indicated (for 
details, see Methods). Reference values (100%) for protein synthesis: 
trophozoites growing in normal RBCs: 663.2 ± 17.2 (counts × 103/
min/mg protein ± SD, n = 3); trophozoites growing in oxidatively 
stressed RBCs: 780.9 ± 67.3 (same); trophozoites growing in G6PD-
deficient RBCs: 503.5 ± 35.1 (same).Malaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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Stage-dependent mRNA expression of parasite antioxidant enzymes (A) and Hsps (B) in parasites growing in normal RBCs Figure 1
Stage-dependent mRNA expression of parasite antioxidant enzymes (A) and Hsps (B) in parasites growing in 
normal RBCs. Schizont stage parasitized normal RBCs separated on mannitol-containing discontinuous Percoll gradient (par-
asitaemia >95%) were mixed with normal RBCs, suspended in growth medium to start synchronous cultures (time 0). Six h 
after reinfection, parasite ring stages were isolated, washed three times and incubated in growth medium. At 13 (early ring 
stage), 16 (late ring stage), 19 (early trophozoite stage), 28 (late trophozoite stage) and 46 (schizont stage) h after reinfection, 
200 μl of parasitized RBCs were lysed and RNA extracted. Changes in mRNA expression were measured using qRT-PCR. For 
details, see Methods. Results are presented as -fold increase over the mRNA level at early ring stage measured 13 h after rein-
fection using the 2-ΔΔCt method. Mean values ± SEM (vertical bars), n = 1–4.
A
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Stage-dependent mRNA expression of parasite antioxidant enzymes and GAPDH (A; B) and Hsps (C) in parasites growing in  oxidatively stressed normal RBCs Figure 2
Stage-dependent mRNA expression of parasite antioxidant enzymes and GAPDH (A; B) and Hsps (C) in para-
sites growing in oxidatively stressed normal RBCs. Changes in mRNA expression were measured using qRT-PCR. For 
details, see legend to Figure 1 and Materials and methods. The results are presented as -fold increase over the mRNA level at 
early ring stage measured 13 h after reinfection using the 2-ΔΔCtt method. Mean values ± SEM (vertical bars), n = 5–7. Significan-
ces vs ring stage levels are indicated with symbols p < 0.001 (***), p < 0.01 (**), p < 0.05 (*).
A
B
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Stage-dependent mRNA expression of parasite antioxidant enzymes (A; B) and HSPs (C) in parasites growing in G6PD-defi- cient (Mediterranean variant) RBCs Figure 3
Stage-dependent mRNA expression of parasite antioxidant enzymes (A; B) and HSPs (C) in parasites growing 
in G6PD-deficient (Mediterranean variant) RBCs. Changes in mRNA expression were measured using qRT-PCR. For 
details, see legend to Figure 1 and Materials and methods. The results are presented as -fold increase over the mRNA level at 
early ring stage measured 13 h after reinfection using the 2-ΔΔCt method. Mean values ± SEM, vertical bars, n = 5–7. Significan-
ces vs ring stage levels are indicated with symbols p < 0.001 (***), p < 0.01 (**), p < 0.05 (*).
A
B
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Comparison of peak -fold mRNA expression at early trophozoite stage (parasites isolated 19 h after reinfection) in parasites  growing in oxidatively stressed normal RBCs (open columns) and in G6PD-deficient RBCs (solid columns) Figure 4
Comparison of peak -fold mRNA expression at early trophozoite stage (parasites isolated 19 h after reinfec-
tion) in parasites growing in oxidatively stressed normal RBCs (open columns) and in G6PD-deficient RBCs 
(solid columns). Significance of stage-matched differences are indicated with symbol p < 0.001 (***). -Fold data from Figure 2 
and Figure 3.
A
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phozoite-parasitized RBCs. This treatment allows
measurement of the PPP flux in the parasite, since the
virus lyses the RBC membrane by selectively binding to
glycophorin A, leaving the parasite membrane intact and
allowing elimination of cytosolic host enzymes [30,32].
Table 3 shows that compared to unstressed trophozoites,
PPP flux was increased 7.1-fold in trophozoites growing
in oxidatively stressed normal RBCs, and 1.9-fold in tro-
phozoites growing in G6PDdeficient RBCs (Mediterra-
nean variant with <5% residual enzyme activity).
Additional oxidative stress by XO/X treatment decreased
PPP flux in trophozoites growing in G6PD-deficient RBC,
indicating parasite damage or death. Compared to
unstressed trophozoites, G6PD enzyme activity measured
in lysates from Sendai-virus treated and oxidatively
stressed trophozoites growing in normal RBCs showed a
two-fold increase but was not modified in parasites grow-
ing in G6PD-deficient RBCs.
Discussion
The rapidly growing and multiplying P. falciparum parasite
generates large amounts of toxic oxidants [1,2]. Both parasite
and host RBC rely on efficient antioxidant systems for sur-
vival. The parasite has two antioxidant defense systems
related to the scavenger molecules reduced glutathione
(GSH) [3-5] and thioredoxins [6] both kept in a predomi-
nantly reduced state by NADPH produced by G6PD, 6-phos-
phogluconate-dehydrogenase, glutathione reductase and
thioredoxin reductase [6-9]. Plasmodium are also well
adapted to survive at temperatures temporarily reaching
41°C during clinical malaria. As much as 2% of P. falciparum
genome appears to encode HSPs expressed at various stages
of the parasite life cycle [13,14]. A recent review [13] lists a
total 95 genes coding for Pf-HSPs and HSP-related proteins,
but only a small number of those has been characterized bio-
chemically and functionally [39-43]. Several studies have
analysed the response of Pf-HSP to hyperthermia [40,41,43-
45], while response of Pf-HSPs to oxidative stress, extensively
studied in pro- and eukaryotic cells lines [19-24], has
received no attention sofar. Pf-HSPs of present study were
selected because they were well-characterized molecules
(HSP60, HSP70, HSP90 [39-43]), localized in mitochondria
(HSP60 [12]) or, by analogy with other cell types, possibly
responsive to oxidative stress (HSP70 [21,24], HSP90 [22])
or potential drug targets (HSP90 [42,43]).
Present work addresses two aspects of parasite defense
against oxidant challenge: first, modulation of expression
of antioxidant enzymes and HSPs during normal parasite
development, and, second, modulation of expression of
both systems in front of increased exogenous and endog-
enous oxidative stress, represented respectively by parasite
growth under a mild and constant flux of hydrogen perox-
ide produced extracellularly by XO/X [34], and growth in
G6PD-deficient RBCs. mRNA expression of ten Pf antioxi-
dant enzymes representative of the glutathione and
thioredoxin system, and five representative and possibly
redox-controlled Pf-HSPs were analysed by qRT-PCR at
early and late ring stage (13 and 16 h after reinfection),
early and late trophozoite stage (19 and 28 h after reinfec-
tion) and late schizont stage (46 h after reinfection).
The results obtained with P. falciparum developing in nor-
mal RBCs show for the first time that both antioxidant
enzymes and HSPs were expressed in a tightly correlated
manner, as both systems peaked at early trophozoite stage
at 19 h after reinfection, declined afterwards, and had very
similar amplification factors between approx. 1.7 and 2.0
relative to mRNA expression at early ring stage. The two
asymmetrical bell-shaped curves observed here appear to
be functionally related to the kinetics of formation of
superoxide anions, the principal generators of ROS mostly
produced during the trophozoite phase when host hae-
moglobin is exposed to the acid environment of the food
vacuole. These results basically agree with recently pub-
lished P. falciparum transcriptome of antioxidant defense
and pentose phosphate pathway enzymes in terms of time
and amplitude of peak expression [46-48]. Studies have
shown that the majority of expression profiles revealed a
striking nonstochastic periodicity marked by a single max-
imum and a single minimum in relative abundance of sin-
gle mRNAs [46,49]. It was also shown that concordance in
time of peaking and amplification of gene transcription,
i.e. peak-to-trough amplitude of the expression profile are
Protein expression of antioxidant enzymes in early tropho- zoite stage parasites growing in normal and oxidatively  stressed RBCs Figure 5
Protein expression of antioxidant enzymes in early 
trophozoite stage parasites growing in normal and 
oxidatively stressed RBCs. Early trophozoite stages were 
isolated from cultured synchronized parasites. Parasites were 
isolated from host RBCs by Sendai-virus treatment and lysed 
by freeze-thawing and sonication. Ten to 15 μg of protein 
extract of control (Column A) and oxidatively stressed (Col-
umn B) trophozoite stages were separated by SDS-PAGE and 
blotted onto nitrocellulose. The blots were hybridized with 
polyclonal antibodies directed against parasite superoxide 
dismutases (SOD-1 and SOD-2), thioredoxin reductase 
(Trx), thioredoxin-dependent peroxidases (1-Cys-Prx, 2-
Cys-Prx), and glutathione reductase (GR), and subsequently 
with the secondary anti-rabbit or rat horseradish-peroxi-
dase-coupled antibody and the bands detected by chemilumi-
nescence and densitometric quantification. Column C shows 
protein expression increases in oxidatively stressed cells vs 
untreated controls, expressed as -fold variation of band den-
sitometry. The results shown are representative from 1–3 
independent experiments. For details, see Methods.Malaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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the major signatures of functionally correlated clusters of
genes [46,50]. Taken in association with the data dis-
cussed below, close temporal and quantitative correlation
in expression of antioxidant enzymes and HSPs can be
considered as a first evidence of functional relatedness
between both classes of molecular agents. Enhanced, co-
ordinated expression of antioxidant enzymes and selected
HSPs discussed before was not a generalized and unspe-
cific consequence of oxidant stress. As an example, expres-
sion of GAPDH, a crucial glycolytic enzyme, was not
responsive to XO/X treatment (see Figure 2).
Response to exogenous oxidative stress was studied in par-
asites growing in normal RBCs subjected to a mild flow of
hydrogen peroxide generated by extracellular XO/X [34].
The results confirmed the flexible and coordinated
response of both antioxidant enzymes and HSPs. All
mRNA species were significantly increased compared to
their stage-parallel counterparts growing in unstressed
RBCs, and displayed similar asymmetrical bell-shaped
expression curves peaking at 19 h after reinfection and
sharply declining at late schizont stage. Expression
increases were not uniform, though. While most mRNAs
responded with between 4 to 8-fold increases, compared
to early ring expression levels, SOD-1, SOD-2, HSP60 and
HSP70–2 were high responders with fold increases
between 12.9 (HSP60) and 15.4 (SOD-1). Interestingly,
HSP70 and HSP90 have been shown in several eukaryotic
cells to be exquisitely sensitive to a variety of stimuli that
increase cellular oxidation [21-24].
Protein expression of small number of antioxidant
enzymes was studied by Western blotting and densitome-
try. Tendentially, high protein expression observed in
SOD-1 and -2, Trx and Px3 corresponded to high mRNA
responders, while GR was a low responder in terms of
both mRNA and protein expression. Increased levels of
protein expression of the 2-Cys peroxiredoxin were previ-
ously observed in parasites stressed with tert-butylhy-
droperoxide and the redox cycler juglone [51]. It should
be remembered that a moderately high positive correla-
tion was shown to exist between mRNA and semiquanti-
tative protein abundance for each stage observed [49].
However, it is not unusual that not all mRNA levels and
the respective protein levels correlate given that it was
shown that post-transcriptional regulatory mechanisms
control gene expression in the parasite [52,53]. On the
other hand it was shown that protein abundance of sev-
eral HSPs, including HSP60, HSP70 and HSP90 showed a
bell-shaped curve peaking at trophozoite stage [14,49],
thus corresponding to the mRNA expression pattern
shown here.
Instead of measuring enzyme activities in cell lysates we
measured the PPP flux in Sendai-virus treated trophozoite-
parasitized RBCs. PPP flux is considered to reflect NADPH
formation by the parasite more closely than G6PD activity
measured in the cell lysate, due to severe restraint of G6PD
activity in the cell [54]. For example, in the human RBC the
maximal activity of G6PD measured in the cell lysate
exceeds the basal PPP rate by over 100-fold [55]. Table 3
shows that compared to unstressed trophozoites, PPP flux
was increased 7.1-fold in trophozoites growing in oxida-
tively stressed RBCs indicating that increase in mRNA
expression of G6PD corresponded to a metabolic response.
The increased flux through PPP is not surprising given that
the redox balance in the parasites is likely to be affected by
the stress applied. The elevated levels of hydrogen peroxide
will almost certainly lead to an increased demand for
NADPH to guarantee that both the thioredoxin redox sys-
tem (employing TR and several peroxiredoxins) as well as
the glutathione redox system (involved in maintaining an
adequate intracellular GSH/GSSG ratio) are able to deal
with the reduction of ROS [2-4,7].
A second model of parasite response to oxidative stress were
parasites growing in G6PD-deficient RBC (Mediterranean
variant with <5% residual activity). Those parasites are sub-
Table 3: PPP flux in trophozoites growing in oxidatively stressed normal RBCs and in G6PD-deficient RBCs
Sample Treatment PPP flux -fold increase
A Trophozoites growing in normal RBCs nil 5.28 ± 0.84
n = 4
1
B Trophozoites growing in oxidatively stressed normal RBCs low XO/X b 37.4 ± 4.5
n = 3
7.1
C Trophozoites growing in G6PDdeficient RBCs nil 10.1 ± 1.3
n = 4
1.9
PPP flux was measured in Sendai-virus treated trophozoites growing in normal RBCs (A), oxidatively stressed RBCs (B) and G6PD-deficient RBCs 
(C). Trophozoite stage parasites were isolated from host RBCs by Sendai-virus treatment and incubated in RPMI 1640 without NaHCO3, but 
containing 1 μCi/ml D- [1-14C] glucose at 5% haematocrit. After 90 min of preincubation at 37°C, PPP flux was measured by quantifying produced 
[14C]-CO2 as indicated (see Methods). Production of [14C]-CO2 is expressed as μmol/1010 cells/h at 37°C. Mean values ± SD of n separate 
experiments as indicated. Significance of experiments: A vs B; A vs C; and B vs C, p < 0.001 bLow XO/X: XO 0.1 mU/ml, see legend to Table 2.Malaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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jected to constantly increased endogenous oxidative stress, as
G6PDdeficient RBCs have low antioxidant defense due to
low steady-state levels of reduced glutathione (GSH) and
severely restricted NADPH production and GSH regenera-
tion kinetics upon oxidative challenge [56]. In addition,
compartment analysis has shown extremely low levels of
GSH in rings developing in G6PD-deficient RBCs [57].
Compared to parasites growing in normal RBCs, parasites
growing in G6PD-deficient cells displayed distinctly
increased stage-dependent mRNA expression of antioxi-
dant enzymes and HSPs, indicating that indeed the parasite
was subjected to massive oxidative stress and responded
with increased expression of protective molecules. While
peak-to-trough ratios between approx. 1.7 and 2 were
observed in parasites developing in normal RBCs, in para-
sites developing in G6PD-deficient RBCs ratios between
approx. 4 and 8.5 were observed in antioxidant enzymes
and HSPs, with the overshooting ratios of 12.8 and 15.8 in
GR and Hsp75, respectively (see Figure 3).
Parasites growing in G6PD-deficient cells displayed similar
stage-dependent increases of mRNA expression in 5/10 anti-
oxidant enzymes and 2/5 HSPs compared to parasites grow-
ing in oxidatively stressed normal RBCs (see Figure 4). Only
the expression of GR and HSP 75 was significantly higher in
parasites growing in G6PD-deficient RBCs, while expression
of TR, SOD-1, SOD-2, G6PD, HSP60 and HSP 70–2 was sig-
nificantly higher in parasites growing in oxidativeley stressed
normal RBCs. Tendentially therefore, the parasite response
to the endogenous (growth in G6PD-deficient RBCSs) and
exogenous oxidant stress was similar but less pronounced in
the former condition. It should be noted that parasite's inva-
sion and growth have been shown to be very similar in nor-
mal and G6PD-deficient RBCs [30], while the G6PD-
deficient host RBC was distinctly altered by the parasite pres-
ence particularly at ring stage [30]. In fact, the parasite has an
independent GSH synthesis machinery largely independent
from the host [3,5] and is apparently subjected to a less
intense oxidative stress compared to the XO/X-treated para-
sites. The overshooting peak expression of GR might have
compensatory character to ensure high levels of GSH regen-
eration in the parasite.
Genome-wide analysis of gene expression of cells exposed
to oxidant stress has shown that the large number of
affected genes are not necessarily functionally intercon-
nected or related to the nature of the stress. The number
of genes considered here was very limited compared to the
total number of parasite genes and it is highly probable
that many other genes are activated or repressed by the
stress employed here. However, a number of elements
make it likely that HSPs play a role in antioxidant defense.
First, as HSPs mediate the correct refolding of denatured
proteins and avoid the formation of aggregates, HSP
involvement in antioxidant defense makes biological
sense as ROS directly or indirectly perturb the structure of
proteins. Indirect protein perturbants are for example
products of lipid (per)oxidation such as 4-hydroxynone-
nal formed in the mature parasites [58]. Secondly, a large
number of studies have documented that HSPs play a role
in antioxidant defense in all eukaryotes and eukaryotic
cell lines examined sofar [see for example ref. [19-24] and
[59-61]]. Thirdly, a recent comparative analysis of hydro-
gen peroxide-induced gene expression modifications
across kingdoms has shown that HSP response, notably
involving HSP20, HSP70 and HSP90, was evolutionarily
conserved and one protein family representing the DNAJ
heat shock proteins was induced by hydrogen peroxide in
all kingdoms [61]. Finally, allopurinol, a specific inhibitor
of the XO/X-elicited production of hydrogen peroxide
[35], abrogated increases in expression of both antioxi-
dant enzymes and HSPs.
Studies of the effects of drugs, such as chloroquine and
artemisinin, on mRNA and protein levels in Plasmodium
suggest a certain degree of correlation between transcrip-
tional response and alteration of protein levels. However,
the amplitude of mRNA changes appears much more pro-
nounced than alterations of protein levels observed in
proteome studies [62]. Surprisingly, Prieto et al [62]
showed that both drugs did not result in a marked up-reg-
ulation of antioxidant proteins despite the fact that both
are thought to increase oxidative stress in the parasites.
The latter is consistent with another study [63] showing
that CQ treatment resulted in a marked elevation of pro-
tein oxidation particularly of numerous HSPs. This is not
surprising as it has been previously observed in other
eukaryotes subjected to oxidative stresses [12]. Concomi-
tantly, components of the proteasome machinery are also
upregulated suggesting that protein degradation might
affect abundance of oxidised proteins [62,63]. These data
suggest that HSP up-regulation might help directly to
remove ROS and that removal of the oxidised proteins by
the parasite's protein degradation machinery protects
them in a more general way from the stresses they encoun-
ter. Future studies will address this possibility.
Mechanisms employed by P. falciparum to regulate gene
expression at the mRNA level are poorly known, and puta-
tive regulatory elements have been sofar only identified in
silico [64]. Recently, the HSP gene family was utilized as a
model system to identify regulatory elements in the P. fal-
ciparum genome [65]. HSP genes do not appear to contain
standard eukaryotic regulatory elements. Instead, a G-rich
regulatory element not homologous to known eukaryotic
elements was identified upstream of several falciparum
HSP genes [65]. It is possible that the expression enhance-
ments shown here are co-ordinated by a common mecha-
nism controlling expression of both antioxidant enzymes
and HSPs. It is intriguing to imagine that a single or few
redox-dependent signaling metabolites may interact withMalaria Journal 2009, 8:113 http://www.malariajournal.com/content/8/1/113
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a common G-box governing coordinated expression of
antioxidant enzymes and HSPs. The ring-to-trophozoite
transition is characterized by enhanced haemoglobin
catabolism [66], liberation of small amounts of haem,
free iron and a number of lipid (per)oxidation products,
such as 4hydroxynonenal, abundantly present in tropho-
zoites [58,67]. Which one of those molecules is responsi-
ble alone or in combination for expression enhancement
is unknown and worth exploring. Of note, 4-hydroxynon-
enal elicited a robust increase in HSP40 and HSP70
expression in a tumor cell line [68].
In conclusion, it has been shown that mRNA expression
of parasite antioxidant enzymes and HSPs was co-ordi-
nated and stage-dependent. Both systems were shown to
be redox-responsive and manifested enhancement of co-
ordinated expression in oxidatively-stressed parasites and
in parasites growing in G6PD-deficient RBCs character-
ized by blunted antioxidant defense. Finally, as wide-
spread and efficient anti-malarials either increase oxidant
stress or inhibit antioxidant defense, present results may
encourage to consider the numerous anti-HSPs molecules
currently developed for anticancer therapy [69-71] as
potential anti-malarials.
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